FFO
FLNA

Fortitude Family Office’s Filana Therapeutics FLNA Stock Holding History

Fortitude Family Office’s Portfolio FLNA Stock Details FLNA Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2025
Q2 		– Sell
-338
Closed -$507 – 2119
2025
Q1 		$507 Hold
338
– – ﹤0.01% 1079
2024
Q4 		$798 Buy
338
+239
+241% +$4.2K ﹤0.01% 1165
2024
Q3 		$2.91K Buy
99
+52
+111% +$1.2K ﹤0.01% 930
2024
Q2 		$580 Buy
47
+30
+176% +$632 ﹤0.01% 916
2024
Q1 		$345 Sell
17
-32
-65% -$737 ﹤0.01% 938
2023
Q4 		$1.1K Buy
+49
New +$1.03K ﹤0.01% 936

Other funds holding FLNA

Vanguard Group
Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return
BlackRock
BlackRock New York $5.72T AUM 30.48% 1-Year Est. Return
Two Sigma Advisers
Two Sigma Advisers New York $51.4B AUM 31.07% 1-Year Est. Return
JP Morgan Chase
JP Morgan Chase New York $1.56T AUM 27.86% 1-Year Est. Return
Goldman Sachs
Goldman Sachs New York $871B AUM 31.28% 1-Year Est. Return
Two Sigma Investments
Two Sigma Investments New York $124B AUM 33.93% 1-Year Est. Return
Geode Capital Management
Geode Capital Management Boston, Massachusetts $1.61T AUM 30.72% 1-Year Est. Return
Millennium Management
Millennium Management New York $240B AUM 35.51% 1-Year Est. Return
Morgan Stanley
Morgan Stanley New York $1.66T AUM 25.57% 1-Year Est. Return
GC
GMT Capital Atlanta, Georgia $2.19B AUM 72.3% 1-Year Est. Return

Fortitude Family Office's FLNA Position: Q2 2025 in Review

Fortitude Family Office sold out of Filana Therapeutics (FLNA) in Q2 2025, closing a stake of 338 shares — an estimated $507 sold.

Fortitude Family Office first reported a position in FLNA in Q4 2023 and held it in 6 quarters. The position peaked at $2.91K in Q3 2024. 97 funds tracked by Wall St. Rank hold FLNA as of Q2 2025.

  • Fortitude Family Office reported no remaining Filana Therapeutics position as of Q2 2025 after selling out during the quarter.
  • Fortitude Family Office sold 338 Filana Therapeutics shares in Q2 2025, an estimated $507.
  • Fortitude Family Office first reported a position in Filana Therapeutics in Q4 2023 and held it in 6 quarters.
  • Fortitude Family Office's Filana Therapeutics position peaked at $2.91K in Q3 2024.
  • 97 funds tracked by Wall St. Rank held Filana Therapeutics as of Q2 2025.

Based on Fortitude Family Office's 13F filing for Q2 2025, filed 15 Jul 2025.